Identification of the Canine Parvovirus Strains from Feces of Diarrhea Dogs in Jeju and Seoul
World Small Animal Veterinary Association World Congress Proceedings, 2007
Nam-hyang Kim; Hae-young Jwa; Young-min Yun; Kyoung-kap Lee*
Department of Veterinary Medicine, Cheju National University
Jeju, Republic of Korea

Canine parvovirus type 2 (CPV-2) emerged as causative agent of severe hemorrhagic gastroenteritis in dogs in 1978. A few years after its emergence, 2 new antigenic types, CPV-2a and CPV-2b have rapidly spread all over the world, whereas the original type 2 (CPV-2) is no longer found in the dog population. Despite vaccination, CPV-2 remains an important cause of disease and is often implicated in fatal infection in young puppies. We examined the canine parvovirus type in Jeju and Seoul area. Forty nine samples that were positive by CPV diagnostic kit in Jeju and Seoul were used in this study. The antigenic type of CPV samples was characterized, using four discriminating primer (CPV-2, CPV-2a, CPV-2b) pairs. In PCR assay, 46 of them (93.9%) were positive by CPV specific primer. Thirty three of them were typed as CPV-2b (71.7%) and 13 were typed as CPV-2a (28.3%), and in this new isolated CPV2b-Jeju3 (98%) and CPV2b-Jeju4 (99%) were similarity to CPV2b-Japan and CPV-407, 436(USA) on the VP2 region of CPV. In this survey, we know that the strain of CPV in Jeju and Seoul area is almost CPV-2a and CPV-2b as like other countries. Some vaccine strain is still CPV old or 2 type, so we should consider the new vaccine strain for the higher antigenicity and antibody titer.

*Corresponding author

Speaker Information
(click the speaker's name to view other papers and abstracts submitted by this speaker)

Kyoungkap Lee
Cheju National University
Republic of Korea


MAIN : Abstracts - Poster : Canine Parvovirus Strains
Powered By VIN

Friendly Reminder to Our Colleagues: Use of VIN content is limited to personal reference by VIN members. No portion of any VIN content may be copied or distributed without the expressed written permission of VIN.

Clinicians are reminded that you are ultimately responsible for the care of your patients. Any content that concerns treatment of your cases should be deemed recommendations by colleagues for you to consider in your case management decisions. Dosages should be confirmed prior to dispensing medications unfamiliar to you. To better understand the origins and logic behind these policies, and to discuss them with your colleagues, click here.

Images posted by VIN community members and displayed via VIN should not be considered of diagnostic quality and the ultimate interpretation of the images lies with the attending clinician. Suggestions, discussions and interpretation related to posted images are only that -- suggestions and recommendations which may be based upon less than diagnostic quality information.

CONTACT US

777 W. Covell Blvd., Davis, CA 95616

vingram@vin.com

PHONE

  • Toll Free: 800-700-4636
  • From UK: 01-45-222-6154
  • From anywhere: (1)-530-756-4881
  • From Australia: 02-6145-2357
SAID=27